Global Bipolar Disorder Therapeutic Market 2019-2023
About Bipolar Disorder
Bipolar disorder is also known as manic depression that causes extreme shifts in mood, energy, and activity levels. Elevated mood swings are called mania or hypomania, which differs based on the severity and presence of psychosis. Bipolar disorder is a long-lasting condition that can be categorized into bipolar I, bipolar II, and cyclothymia. This condition can be managed with a regular treatment. Insomnia, weight gain or loss, behavioral changes, and psychological imbalances are some of the symptoms witnessed in individuals with bipolar disorder.
Technavio’s analysts forecast the Global Bipolar Disorder Therapeutics Market to grow at a CAGR of 2.38% during the period 2019-2023.
Covered in this report
The report covers the present scenario and the growth prospects of the bipolar disorder therapeutics market. To calculate the market size, the report considers the revenue generated from the application of bipolar disorder therapeutics across the globe.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report - Global Bipolar Disorder Therapeutics Market 2019-2023
Technavio recognizes the following companies as the key players in the global bipolar disorder therapeutics market: Allergan, AstraZeneca, Eli Lilly, GlaxoSmithKline, and Johnson & Johnson.
Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the growing number of strategic alliances between vendors. Most of the vendors are focused on entering into strategic alliances to develop the most effective treatment for bipolar treatment and expand their product portfolio.”
According to the report, one driver influencing this market is the growing prevalence of mental health disorders (MHDs) across the globe. The rising incidences of these MHDs is resulting in a great need for the development of the most effective treatment for bipolar disorder.
Further, the report states that one challenge affecting this market is the lack of adequate diagnosis process. The lack of a proper technical diagnostic process is a key challenge in the global bipolar disorder therapeutics market.
Johnson & Johnson
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook